JP2009509976A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009509976A5 JP2009509976A5 JP2008532503A JP2008532503A JP2009509976A5 JP 2009509976 A5 JP2009509976 A5 JP 2009509976A5 JP 2008532503 A JP2008532503 A JP 2008532503A JP 2008532503 A JP2008532503 A JP 2008532503A JP 2009509976 A5 JP2009509976 A5 JP 2009509976A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- platelet
- group
- composition according
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 40
- 238000000034 method Methods 0.000 claims 14
- 208000027418 Wounds and injury Diseases 0.000 claims 11
- 206010052428 Wound Diseases 0.000 claims 10
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 8
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 8
- 239000012636 effector Substances 0.000 claims 8
- 210000002744 extracellular matrix Anatomy 0.000 claims 8
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 claims 7
- 239000003112 inhibitor Substances 0.000 claims 7
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 claims 6
- 239000011159 matrix material Substances 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 230000010118 platelet activation Effects 0.000 claims 6
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 claims 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 4
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 claims 4
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims 4
- 229960005305 adenosine Drugs 0.000 claims 4
- 229960002576 amiloride Drugs 0.000 claims 4
- 239000002577 cryoprotective agent Substances 0.000 claims 4
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 claims 4
- 229940083618 sodium nitroprusside Drugs 0.000 claims 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 229940126121 sodium channel inhibitor Drugs 0.000 claims 3
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 2
- XHTUOWXUBNMVEU-UHFFFAOYSA-N 1-benzoyl-5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione Chemical group O=C1C(CC)(CCC(C)C)C(=O)NC(=O)N1C(=O)C1=CC=CC=C1 XHTUOWXUBNMVEU-UHFFFAOYSA-N 0.000 claims 2
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 claims 2
- NCGICGYLBXGBGN-UHFFFAOYSA-N 3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine;hydrochloride Chemical compound Cl.[N-]1OC(=N)C=[N+]1N1CCOCC1 NCGICGYLBXGBGN-UHFFFAOYSA-N 0.000 claims 2
- DVKQVRZMKBDMDH-UUOKFMHZSA-N 8-Br-cAMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1Br DVKQVRZMKBDMDH-UUOKFMHZSA-N 0.000 claims 2
- 101800001288 Atrial natriuretic factor Proteins 0.000 claims 2
- 102400001282 Atrial natriuretic peptide Human genes 0.000 claims 2
- 101800001890 Atrial natriuretic peptide Proteins 0.000 claims 2
- 102000019034 Chemokines Human genes 0.000 claims 2
- 108010012236 Chemokines Proteins 0.000 claims 2
- 102000009016 Cholera Toxin Human genes 0.000 claims 2
- 108010049048 Cholera Toxin Proteins 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- 102000004237 Decorin Human genes 0.000 claims 2
- 108090000738 Decorin Proteins 0.000 claims 2
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 102000016942 Elastin Human genes 0.000 claims 2
- 108010014258 Elastin Proteins 0.000 claims 2
- 102000017177 Fibromodulin Human genes 0.000 claims 2
- 108010013996 Fibromodulin Proteins 0.000 claims 2
- 102000016359 Fibronectins Human genes 0.000 claims 2
- 108010067306 Fibronectins Proteins 0.000 claims 2
- DJBNUMBKLMJRSA-UHFFFAOYSA-N Flecainide Chemical compound FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(C(=O)NCC2NCCCC2)=C1 DJBNUMBKLMJRSA-UHFFFAOYSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims 2
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 2
- 102000007547 Laminin Human genes 0.000 claims 2
- 108010085895 Laminin Proteins 0.000 claims 2
- 229920002774 Maltodextrin Polymers 0.000 claims 2
- 239000005913 Maltodextrin Substances 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- 102400000050 Oxytocin Human genes 0.000 claims 2
- 101800000989 Oxytocin Proteins 0.000 claims 2
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 claims 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims 2
- 102000016611 Proteoglycans Human genes 0.000 claims 2
- 108010067787 Proteoglycans Proteins 0.000 claims 2
- -1 SIN-1A Chemical compound 0.000 claims 2
- 206010072170 Skin wound Diseases 0.000 claims 2
- 102000011923 Thyrotropin Human genes 0.000 claims 2
- 108010061174 Thyrotropin Proteins 0.000 claims 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 2
- 208000025865 Ulcer Diseases 0.000 claims 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 2
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims 2
- 108010004977 Vasopressins Proteins 0.000 claims 2
- 102000002852 Vasopressins Human genes 0.000 claims 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims 2
- UIEATEWHFDRYRU-UHFFFAOYSA-N bepridil Chemical compound C1CCCN1C(COCC(C)C)CN(C=1C=CC=CC=1)CC1=CC=CC=C1 UIEATEWHFDRYRU-UHFFFAOYSA-N 0.000 claims 2
- 229960003665 bepridil Drugs 0.000 claims 2
- NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 229960002086 dextran Drugs 0.000 claims 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 claims 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 229920002549 elastin Polymers 0.000 claims 2
- 229960001123 epoprostenol Drugs 0.000 claims 2
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims 2
- 102000013370 fibrillin Human genes 0.000 claims 2
- 108060002895 fibrillin Proteins 0.000 claims 2
- 229960000449 flecainide Drugs 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 229960001031 glucose Drugs 0.000 claims 2
- 235000001727 glucose Nutrition 0.000 claims 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 230000036571 hydration Effects 0.000 claims 2
- 238000006703 hydration reaction Methods 0.000 claims 2
- 229940050526 hydroxyethylstarch Drugs 0.000 claims 2
- 229960002240 iloprost Drugs 0.000 claims 2
- HIFJCPQKFCZDDL-ACWOEMLNSA-N iloprost Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]21 HIFJCPQKFCZDDL-ACWOEMLNSA-N 0.000 claims 2
- 229940039009 isoproterenol Drugs 0.000 claims 2
- 229940035034 maltodextrin Drugs 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000001272 nitrous oxide Substances 0.000 claims 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 claims 2
- 229960001723 oxytocin Drugs 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- RPQXVSUAYFXFJA-HGRQIUPRSA-N saxitoxin Chemical compound NC(=O)OC[C@@H]1N=C(N)N2CCC(O)(O)[C@@]22N=C(N)N[C@@H]12 RPQXVSUAYFXFJA-HGRQIUPRSA-N 0.000 claims 2
- RPQXVSUAYFXFJA-UHFFFAOYSA-N saxitoxin hydrate Natural products NC(=O)OCC1N=C(N)N2CCC(O)(O)C22NC(N)=NC12 RPQXVSUAYFXFJA-UHFFFAOYSA-N 0.000 claims 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 2
- 229960000278 theophylline Drugs 0.000 claims 2
- 229960000874 thyrotropin Drugs 0.000 claims 2
- 230000001748 thyrotropin Effects 0.000 claims 2
- 231100000397 ulcer Toxicity 0.000 claims 2
- 229960003726 vasopressin Drugs 0.000 claims 2
- 208000034656 Contusions Diseases 0.000 claims 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims 1
- 206010011985 Decubitus ulcer Diseases 0.000 claims 1
- 206010056340 Diabetic ulcer Diseases 0.000 claims 1
- 206010016717 Fistula Diseases 0.000 claims 1
- 206010017711 Gangrene Diseases 0.000 claims 1
- 208000004210 Pressure Ulcer Diseases 0.000 claims 1
- 108010052164 Sodium Channels Proteins 0.000 claims 1
- 102000018674 Sodium Channels Human genes 0.000 claims 1
- UGPMCIBIHRSCBV-XNBOLLIBSA-N Thymosin beta 4 Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(C)=O UGPMCIBIHRSCBV-XNBOLLIBSA-N 0.000 claims 1
- 102100035000 Thymosin beta-4 Human genes 0.000 claims 1
- 208000000558 Varicose Ulcer Diseases 0.000 claims 1
- AUJRCFUBUPVWSZ-XTZHGVARSA-M auranofin Chemical compound CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O AUJRCFUBUPVWSZ-XTZHGVARSA-M 0.000 claims 1
- 229960005207 auranofin Drugs 0.000 claims 1
- 208000034526 bruise Diseases 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 230000003890 fistula Effects 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 229940029575 guanosine Drugs 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 150000004712 monophosphates Chemical class 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 210000004872 soft tissue Anatomy 0.000 claims 1
- 108010079996 thymosin beta(4) Proteins 0.000 claims 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72085105P | 2005-09-26 | 2005-09-26 | |
| US60/720,851 | 2005-09-26 | ||
| PCT/US2006/037741 WO2007038629A2 (en) | 2005-09-26 | 2006-09-26 | Dry platelet composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009509976A JP2009509976A (ja) | 2009-03-12 |
| JP2009509976A5 true JP2009509976A5 (enExample) | 2009-11-12 |
| JP5478884B2 JP5478884B2 (ja) | 2014-04-23 |
Family
ID=37900439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008532503A Expired - Fee Related JP5478884B2 (ja) | 2005-09-26 | 2006-09-26 | 乾燥血小板組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20090035289A1 (enExample) |
| EP (1) | EP1929289B1 (enExample) |
| JP (1) | JP5478884B2 (enExample) |
| AU (1) | AU2006294654B2 (enExample) |
| CA (1) | CA2623666C (enExample) |
| ES (1) | ES2668551T3 (enExample) |
| WO (1) | WO2007038629A2 (enExample) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2319548B1 (en) * | 2008-08-14 | 2016-06-01 | KCI Licensing, Inc. | Tissue scaffolds |
| JP2012509153A (ja) * | 2008-11-20 | 2012-04-19 | ライフセル コーポレーション | 傍ストーマヘルニアの治療及び予防のための方法 |
| AU2009316588B2 (en) | 2008-11-21 | 2014-09-11 | Stout Medical Group, L.P. | Reinforced biologic material |
| US8469779B1 (en) | 2009-01-02 | 2013-06-25 | Lifecell Corporation | Method for debristling animal skin |
| US9649408B1 (en) | 2009-11-05 | 2017-05-16 | Lifecell Corporation | Systems and methods for sterilization of bone or bone components |
| EP2536340B1 (en) * | 2010-02-19 | 2018-10-17 | LifeCell Corporation | Abdominal wall treatment devices |
| AU2011232374B2 (en) * | 2010-03-25 | 2015-06-25 | Lifecell Corporation | Preparation of regenerative tissue scaffolds |
| US9999702B2 (en) | 2010-04-09 | 2018-06-19 | Kci Licensing Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
| AU2011276246B2 (en) | 2010-07-08 | 2014-12-04 | Lifecell Corporation | Method for shaping tissue matrices |
| TWI422385B (zh) * | 2010-10-06 | 2014-01-11 | Central Medical Technologies Inc | Hair growth agent containing platelet dry powder |
| CA2829118A1 (en) * | 2011-03-09 | 2012-09-13 | Charles E. Worden | Wound healant system and methods of use |
| US8597264B2 (en) | 2011-03-24 | 2013-12-03 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
| EP2508892A1 (de) * | 2011-04-04 | 2012-10-10 | Siemens Healthcare Diagnostics Products GmbH | Kontrollen und Kit für Thrombozytenaktivitätsteste |
| BR112013026200A2 (pt) | 2011-04-14 | 2019-08-27 | Lifecell Corp | método para preparar uma composição de matriz de tecido, e matriz de tecido |
| EP3851131A1 (en) | 2011-05-31 | 2021-07-21 | LifeCell Corporation | Adipose tissue matrices |
| US9089523B2 (en) | 2011-07-28 | 2015-07-28 | Lifecell Corporation | Natural tissue scaffolds as tissue fillers |
| US9532863B2 (en) | 2011-12-20 | 2017-01-03 | Lifecell Corporation | Sheet tissue products |
| CA2859657C (en) | 2011-12-20 | 2021-03-02 | Lifecell Corporation | Acellular tissue matrix particles and flowable products comprising them |
| CA2861048C (en) | 2012-01-24 | 2021-01-12 | Lifecell Corporation | Elongated tissue matrices |
| WO2013134009A1 (en) | 2012-03-08 | 2013-09-12 | Lifecell Corporation | Enzyme-activated collagen and tissue matrices |
| BR112014026090A8 (pt) | 2012-04-24 | 2019-08-27 | Lifecell Corp | composição de matriz tecidual apta a fluir |
| TWI448312B (zh) * | 2012-05-23 | 2014-08-11 | An implant of freeze - dried platelets and its coating method | |
| TWI448310B (zh) * | 2012-05-23 | 2014-08-11 | Medical dressings and their coating methods for frozen freeze - dried platelets | |
| WO2014008184A1 (en) | 2012-07-05 | 2014-01-09 | Lifecell Corporation | Tissue-based drain manifolds |
| ES2753156T3 (es) | 2012-07-13 | 2020-04-07 | Lifecell Corp | Procedimientos de tratamiento mejorado de tejido adiposo |
| EP3332816B1 (en) | 2012-09-26 | 2020-11-04 | LifeCell Corporation | Processed adipose tissue |
| CN108042849B (zh) | 2013-02-06 | 2021-04-20 | 生命细胞公司 | 用于组织产物的局部改性的方法 |
| EP2976095B1 (en) * | 2013-03-15 | 2020-12-23 | 3M Innovative Properties Company | Wound healing compositions |
| HK1194912A2 (en) * | 2013-09-17 | 2014-10-24 | Bestop Group Holdings Ltd | Growth factor concentrate and the use thereof |
| CN104906052B (zh) * | 2014-03-14 | 2017-09-05 | 复旦大学附属中山医院 | 一种自体来源富血小板血浆冻干粉的制备方法 |
| US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
| US20170369845A1 (en) * | 2014-12-31 | 2017-12-28 | Anthrogenesis Corporation | Methods for isolation of platelets |
| CN108697828A (zh) | 2016-02-11 | 2018-10-23 | 生命细胞公司 | 用于稳定包含胶原蛋白的组织产品防止酶降解的方法 |
| WO2017210109A1 (en) | 2016-06-03 | 2017-12-07 | Lifecell Corporation | Methods for localized modification of tissue products |
| CN109862899A (zh) * | 2016-06-16 | 2019-06-07 | 护眼国际有限责任公司 | 治疗干眼综合征及其他创伤性非角质化上皮表面的组合物和方法 |
| ES2841427T3 (es) | 2016-07-05 | 2021-07-08 | Lifecell Corp | Matrices de tejido que incorporan múltiples tipos de tejido |
| AU2017382173A1 (en) | 2016-12-22 | 2019-06-06 | Lifecell Corporation | Devices and methods for tissue cryomilling |
| CN107047538B (zh) * | 2017-03-16 | 2021-04-13 | 苏州大学 | 蛋白激酶a激活剂在血小板保存中的应用及血小板保存方法 |
| JP7297739B2 (ja) | 2017-10-18 | 2023-06-26 | ライフセル コーポレーション | 脂肪組織製品および製造方法 |
| US11123375B2 (en) | 2017-10-18 | 2021-09-21 | Lifecell Corporation | Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products |
| JP7463273B2 (ja) | 2017-10-19 | 2024-04-08 | ライフセル コーポレーション | 流動性無細胞組織マトリックス製品および製造方法 |
| US11246994B2 (en) | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
| JP6391872B1 (ja) * | 2018-03-30 | 2018-09-19 | セルソース株式会社 | 成長因子混合物およびその調製方法 |
| EP3849570A4 (en) * | 2018-09-11 | 2023-07-12 | Cellphire Inc. | Blood plasma-containing compositions |
| EP3887404A4 (en) * | 2018-11-30 | 2022-11-02 | Cellphire, Inc. | SLIDES LOADED WITH ANTI-CANCER AGENTS |
| US11767511B2 (en) | 2018-11-30 | 2023-09-26 | Cellphire, Inc. | Platelets as delivery agents |
| EP3902551A1 (en) | 2018-12-26 | 2021-11-03 | Kim, Katherine, Echo | Compositions and methods for treating burns, wounds, and skin disorders |
| CA3138529C (en) | 2019-05-03 | 2025-10-07 | Cellphire, Inc. | MATERIALS AND PROCESSES FOR THE PRODUCTION OF BLOOD PRODUCTS |
| EP3976127B1 (en) | 2019-05-30 | 2025-09-24 | LifeCell Corporation | Biologic breast implant |
| WO2021034719A1 (en) | 2019-08-16 | 2021-02-25 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
| JP7058431B2 (ja) * | 2019-12-12 | 2022-04-22 | 国立大学法人千葉大学 | 巨核球および血小板を含む凍結乾燥製剤 |
| CA3170196A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
| CN111537326B (zh) * | 2020-05-07 | 2023-05-16 | 天津德祥生物技术股份有限公司 | 制备冻干血小板的方法及其应用 |
| US12532881B2 (en) | 2020-08-19 | 2026-01-27 | Lifecell Corporation | Tissue packaging and method of using same |
| EP4281075A2 (en) * | 2021-01-25 | 2023-11-29 | Pharmi Norden AB | Method of treating a skin disorder by administering an amiloride derivative |
| TW202245814A (zh) | 2021-02-17 | 2022-12-01 | 美商賽菲爾公司 | 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物 |
| US12702682B2 (en) | 2021-11-04 | 2026-08-11 | Cellphire, Inc. | Platelet derivative compositions, and methods of making and using such compositions |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4004975A (en) * | 1975-12-30 | 1977-01-25 | The United States Of America As Represented By The Secretary Of The Navy | Method of isolating and cryopreserving human white cells from whole blood |
| CA1216518A (en) | 1982-11-01 | 1987-01-13 | Gail A. Rock | Plasma-free medium for platelet storage |
| US4676070A (en) | 1984-11-30 | 1987-06-30 | The Board Of Regents, The University Of Texas | Apparatus and method for cryopreparing biological tissue |
| US4865871A (en) | 1983-08-23 | 1989-09-12 | Board Of Regents The University Of Texas System | Method for cryopreparing biological tissue |
| US4799361A (en) | 1983-08-23 | 1989-01-24 | Board Of Regents, The University Of Texas System | Method for cryopreparing biological tissue for ultrastructural analysis |
| US4665088A (en) * | 1984-11-14 | 1987-05-12 | The Research Foundation Of State University Of New York | (E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides |
| US4619257A (en) | 1984-11-30 | 1986-10-28 | Board Of Regents, The University Of Texas System | Apparatus and method for cryopreparing corneal tissue for surgical procedures |
| US4774088A (en) * | 1986-01-08 | 1988-09-27 | The United States Of America As Represented By The Deptment Of Health And Human Services | Method and additives for improving the quality and shelf life of stored blood |
| JPS6360931A (ja) * | 1986-08-29 | 1988-03-17 | Noboru Sato | 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法 |
| US4940581A (en) * | 1986-10-30 | 1990-07-10 | The University Of Tennessee Research Corporation | Platelet cryopreservation |
| US4764463A (en) * | 1986-10-30 | 1988-08-16 | The University Of Tennessee Research Corporation | Platelet cyropreservation |
| US5044165A (en) | 1986-12-03 | 1991-09-03 | Board Of Regents, The University Of Texas | Cryo-slammer |
| US5573678A (en) * | 1987-01-30 | 1996-11-12 | Baxter International Inc. | Blood processing systems and methods for collecting mono nuclear cells |
| DE3717337A1 (de) | 1987-05-22 | 1988-12-15 | Hoechst Ag | Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen, speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern |
| DK293888A (da) * | 1987-06-09 | 1988-12-10 | Takeda Chemical Industries Ltd | Fenolderivater og deres fremstilling og anvendelse |
| MX164619B (es) | 1988-03-02 | 1992-09-09 | Vicente Parrilla Cerrillo | Composicion para el tratamiento de lesiones cutaneas |
| US5256559A (en) * | 1988-03-04 | 1993-10-26 | Biogen, Inc. | Methods and compositions for inhibiting platelet aggregation |
| US5045446A (en) | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
| US5153004A (en) * | 1989-06-02 | 1992-10-06 | Cryopharm Corporation | Freezing and thawing of erythrocytes |
| US5043261A (en) * | 1989-04-10 | 1991-08-27 | Cryopharm Corporation | Lyophilized and reconstituted red blood cell and hemosome compositions |
| US6007978A (en) * | 1988-05-18 | 1999-12-28 | Cobe Laboratories, Inc. | Method of freezing cells and cell-like materials |
| US5958670A (en) * | 1988-05-18 | 1999-09-28 | Cobe Laboratories, Inc. | Method of freezing cells and cell-like materials |
| IL90188A0 (en) | 1988-05-18 | 1989-12-15 | Cryopharm Corp | Process and medium for the lyophilization of erythrocytes |
| US4994367A (en) * | 1988-10-07 | 1991-02-19 | East Carolina University | Extended shelf life platelet preparations and process for preparing the same |
| JPH02129127A (ja) | 1988-11-04 | 1990-05-17 | Sumitomo Seika Chem Co Ltd | 改良された赤血球保存液 |
| FI904329A0 (fi) | 1988-12-05 | 1990-09-03 | Biogen Inc | Foerfaranden och kompositioner foer inhibering av tronbocytaggregation. |
| GB8902791D0 (en) * | 1989-02-08 | 1989-03-30 | Secr Defence | A method of freezing blood |
| US4964280A (en) | 1989-08-17 | 1990-10-23 | Board Of Regents | Method and apparatus for cryopreparing biological tissue |
| US5154007A (en) | 1989-08-17 | 1992-10-13 | Board Of Regents University Of Texas System | Method and apparatus for cryopreparing biological tissue |
| IL95912A (en) | 1989-10-06 | 1998-08-16 | American Nat Red Cross | Method for prolonging the shelf life or red blood cells |
| DD288316A5 (de) | 1989-10-11 | 1991-03-28 | Beziksinstitut F. Blutspende- U. Transfusionswesen,De | Verfahren zur regenerierung von gelagerten erythrozytenkonzentraten |
| US5118512A (en) * | 1990-01-23 | 1992-06-02 | Osteotech, Inc. (A Delaware Corp.) | Process for cryopreserving biological materials and materials prepared thereby |
| WO1991018504A1 (en) | 1990-05-25 | 1991-12-12 | Cryopharm Corporation | Process for lyophilizing cells, cell-like materials and platelets in a mixture of biocompatible amphipathic polymers |
| AU650045B2 (en) | 1990-09-12 | 1994-06-09 | Lifecell Corporation | Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions |
| US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
| US5242792A (en) * | 1991-02-25 | 1993-09-07 | The United States Of America As Represented By The Secretary Of The Navy | Method for the preservation of red blood cells by lyophilization using glycerol or inositol with disaccharides |
| GB9114202D0 (en) | 1991-07-01 | 1991-08-21 | Quadrant Holdings Cambridge | Blood products |
| IL104470A0 (en) | 1992-01-21 | 1993-05-13 | Cryopharm Corp | Process for freezing cells and cell like materials and compositions prepared thereby |
| US5552267A (en) * | 1992-04-03 | 1996-09-03 | The Trustees Of Columbia University In The City Of New York | Solution for prolonged organ preservation |
| EP0642301B1 (en) | 1992-05-29 | 2003-03-12 | The University Of North Carolina At Chapel Hill | Pharmaceutically acceptable fixed-dried human blood platelets |
| US5378601A (en) | 1992-07-24 | 1995-01-03 | Montefiore Medical Center | Method of preserving platelets with apyrase and an antioxidant |
| US5891617A (en) | 1993-09-15 | 1999-04-06 | Organogenesis Inc. | Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing |
| DE69534151T2 (de) | 1994-02-22 | 2006-01-12 | Nippon Telegraph And Telephone Corp. | Gefriergetrocknete Blutzellen, Stammzellen und Plättchen und Verfahren zu deren Herstellung |
| JP3788522B2 (ja) * | 1994-02-22 | 2006-06-21 | 日本電信電話株式会社 | 血球、幹細胞、および血小板の凍結乾燥生成物の製造方法 |
| US5919614A (en) * | 1994-10-19 | 1999-07-06 | Lifecell Corporation | Composition comprising three platelet lesion inhibitors for platelet storage |
| US5622867A (en) * | 1994-10-19 | 1997-04-22 | Lifecell Corporation | Prolonged preservation of blood platelets |
| US6221669B1 (en) * | 1994-10-19 | 2001-04-24 | Lifecell Corporation | Prolonged preservation of blood platelets |
| US5580714A (en) * | 1995-03-08 | 1996-12-03 | Celox Laboratories, Inc. | Cryopreservation solution |
| US5601972A (en) * | 1995-03-24 | 1997-02-11 | Organ, Inc. | Long term storage of red cells in unfrozen solution |
| US5629145A (en) * | 1995-03-24 | 1997-05-13 | Organ, Inc. | Cryopreservation of cell suspensions |
| US5736313A (en) * | 1995-10-20 | 1998-04-07 | The United States Of America As Represented By The Secretary Of The Navy | Method of lyophilizing platelets by incubation with high carbohydrate concentrations and supercooling prior to freezing |
| US6037116A (en) * | 1996-06-14 | 2000-03-14 | Biostore New Zealand, Ltd. | Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials |
| US5750330A (en) * | 1996-06-19 | 1998-05-12 | Litron Laboratories | Method and composition for lyophilizing red blood cells |
| DE19634313A1 (de) * | 1996-08-24 | 1998-02-26 | Behringwerke Ag | Methode zur Stabilisierung von Plättchen |
| US5789151A (en) | 1997-05-15 | 1998-08-04 | The Regents Of The University Of California | Prolonged cold storage of red blood cells by oxygen removal and additive usage |
| AT407484B (de) | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
| US6139878A (en) * | 1998-04-27 | 2000-10-31 | Aventis Behring, Llc | Method for preparing a diafiltered stabilized blood product |
| CA2332986C (en) * | 1998-05-26 | 2009-09-08 | Lifecell Corporation | Cryopreservation of human red blood cells |
| US6933326B1 (en) | 1998-06-19 | 2005-08-23 | Lifecell Coporation | Particulate acellular tissue matrix |
| US6045990A (en) * | 1998-07-09 | 2000-04-04 | Baust; John M. | Inclusion of apoptotic regulators in solutions for cell storage at low temperature |
| US6176089B1 (en) * | 1998-10-27 | 2001-01-23 | Modex Th{acute over (e)}rapeutics | Methods and compositions for cryopreservation of cells and tissues |
| US20020076445A1 (en) * | 2000-02-10 | 2002-06-20 | Crowe John H. | Eukaryotic cells and method for preserving cells |
| EP1255439A4 (en) | 2000-02-10 | 2007-01-03 | Univ California | THERAPEUTIC PLATES AND METHOD |
| CN101072506B (zh) * | 2004-08-12 | 2010-05-12 | 塞尔菲乐有限公司 | 制备冻干血小板的方法、包括冻干血小板的组合物和使用方法 |
| US7846845B2 (en) | 2006-10-26 | 2010-12-07 | Applied Materials, Inc. | Integrated method for removal of halogen residues from etched substrates in a processing system |
| WO2008151257A2 (en) * | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2624828T3 (es) * | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
-
2006
- 2006-09-26 ES ES06815615.7T patent/ES2668551T3/es active Active
- 2006-09-26 AU AU2006294654A patent/AU2006294654B2/en not_active Ceased
- 2006-09-26 WO PCT/US2006/037741 patent/WO2007038629A2/en not_active Ceased
- 2006-09-26 CA CA2623666A patent/CA2623666C/en active Active
- 2006-09-26 US US12/088,067 patent/US20090035289A1/en not_active Abandoned
- 2006-09-26 JP JP2008532503A patent/JP5478884B2/ja not_active Expired - Fee Related
- 2006-09-26 EP EP06815615.7A patent/EP1929289B1/en not_active Not-in-force
-
2016
- 2016-12-01 US US15/366,768 patent/US10179150B2/en active Active
-
2018
- 2018-12-10 US US16/214,896 patent/US20190175655A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2623666C (en) | Dry platelet composition | |
| Goodarzi et al. | Tissue engineered skin substitutes | |
| Ulubayram et al. | EGF containing gelatin-based wound dressings | |
| Hunt et al. | Physiology of wound healing | |
| Moura et al. | Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice | |
| US20080213238A1 (en) | Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair | |
| EP1263485A1 (en) | Multilayer collagen matrix for tissue reconstruction | |
| JP2005530768A (ja) | 血漿または血清を含有した創傷治療用医薬組成物 | |
| WO2013062994A1 (en) | Compositions and methods for treating full thickness burn injuries | |
| Dwivedi et al. | Current state and future perspective of diabetic wound healing treatment: present evidence from clinical trials | |
| AU2015370982A1 (en) | Methods for wound healing | |
| US12582744B2 (en) | Dressings comprising platelet lysate | |
| Kogan et al. | Biologics in acute burn injury | |
| Petrova et al. | Emerging drugs for diabetic foot ulcers | |
| Santhanam et al. | Bovine based collagen dressings in wound care management | |
| CN110841104B (zh) | 一种红景天苷-胶原蛋白海绵支架的制备方法及在皮肤创伤修复的应用 | |
| CN101040616B (zh) | 药物羊膜及其制备方法 | |
| CN115770318A (zh) | 一种复合多孔止血敷贴及其应用 | |
| Günyaktı et al. | Layered fibrous scaffolds/membranes in wound healing | |
| KR20070113876A (ko) | 혈장성분을 함유하는 창상 치료용 약학 조성물 | |
| Senturk et al. | Wound healing applications of nanomaterials | |
| US20080102106A1 (en) | Wound Healing Composition Comprising Substances From Diptera Larvae | |
| Kumar et al. | Potential of stem cells in combination with natural and synthetic polymer hydrogel for wound healing dressing | |
| Banerjee et al. | Therapeutic benefits of treating chronic diabetic wounds with placental membrane allografts | |
| Levenson et al. | Accelerating effects of nonviable Staphylococcus aureus, its cell wall, and cell wall peptidoglycan |